Pharmacologic, nonhormonal treatment of impotence. Evaluation of associated factors

M. Savion; E. Secenreich; E. Kahan; C. Servadio

doi:10.1016/0090-4295(87)90040-9

Pharmacologic, nonhormonal treatment of impotence. Evaluation of associated factors

M. Savion^*, E. Secenreich, E. Kahan, C. Servadio

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

A group of impotent patients previously treated with Strychiomel was evaluated. Strychiomel is a compound of three drugs, yohimbine, thioridazine (Mellaril), and strychnine sulfate, each of which has a specific effect. The results suggest that the compound drug may be beneficial in the majority of patients (66.7%) when impotence occurs without hormonal or severe vascular or psychologic problems. Other factors such as age or presence of other simultaneous diseases do not appear to be significant when treatment with this multiaction drug (Strychiomel) is utilized.

Original language	English
Pages (from-to)	510-512
Number of pages	3
Journal	Urology
Volume	29
Issue number	5
DOIs	https://doi.org/10.1016/0090-4295(87)90040-9
State	Published - May 1987
Externally published	Yes

Access to Document

10.1016/0090-4295(87)90040-9

Cite this

@article{95f617f967f6473e84e9328778734786,

title = "Pharmacologic, nonhormonal treatment of impotence. Evaluation of associated factors",

abstract = "A group of impotent patients previously treated with Strychiomel was evaluated. Strychiomel is a compound of three drugs, yohimbine, thioridazine (Mellaril), and strychnine sulfate, each of which has a specific effect. The results suggest that the compound drug may be beneficial in the majority of patients (66.7%) when impotence occurs without hormonal or severe vascular or psychologic problems. Other factors such as age or presence of other simultaneous diseases do not appear to be significant when treatment with this multiaction drug (Strychiomel) is utilized.",

author = "M. Savion and E. Secenreich and E. Kahan and C. Servadio",

year = "1987",

month = may,

doi = "10.1016/0090-4295(87)90040-9",

language = "אנגלית",

volume = "29",

pages = "510--512",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Pharmacologic, nonhormonal treatment of impotence. Evaluation of associated factors

AU - Savion, M.

AU - Secenreich, E.

AU - Kahan, E.

AU - Servadio, C.

PY - 1987/5

Y1 - 1987/5

N2 - A group of impotent patients previously treated with Strychiomel was evaluated. Strychiomel is a compound of three drugs, yohimbine, thioridazine (Mellaril), and strychnine sulfate, each of which has a specific effect. The results suggest that the compound drug may be beneficial in the majority of patients (66.7%) when impotence occurs without hormonal or severe vascular or psychologic problems. Other factors such as age or presence of other simultaneous diseases do not appear to be significant when treatment with this multiaction drug (Strychiomel) is utilized.

AB - A group of impotent patients previously treated with Strychiomel was evaluated. Strychiomel is a compound of three drugs, yohimbine, thioridazine (Mellaril), and strychnine sulfate, each of which has a specific effect. The results suggest that the compound drug may be beneficial in the majority of patients (66.7%) when impotence occurs without hormonal or severe vascular or psychologic problems. Other factors such as age or presence of other simultaneous diseases do not appear to be significant when treatment with this multiaction drug (Strychiomel) is utilized.

UR - http://www.scopus.com/inward/record.url?scp=0023214552&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(87)90040-9

DO - 10.1016/0090-4295(87)90040-9

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0023214552

SN - 0090-4295

VL - 29

SP - 510

EP - 512

JO - Urology

JF - Urology

IS - 5

ER -

Pharmacologic, nonhormonal treatment of impotence. Evaluation of associated factors

Abstract

Access to Document

Other files and links

Fingerprint

Cite this